• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[照亮阴影——mRNA疫苗不良事件的观点——机制、风险与管理]:一篇综述

[Illuminating the shadows - perspectives on mRNA vaccine adverse events - mechanisms, risks and management]: A review.

作者信息

Kang Haobo, Sun Yubo, Fang Zhenchi, Ding Weijie, Bai Tianyuan, Yang Kun, Jiang Dongbo

机构信息

Department of Immunology, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University), Xi'an 710032, Shaanxi, China.

Department of Immunology, Basic Medicine School, Air Force Medical University (the Fourth Military Medical University), Xi'an 710032, Shaanxi, China; The Key Laboratory of Bio-Hazard Damage and Prevention Medicine, Basic Medicine School, Air-Force Medical University (The Fourth Military Medical University), Xi'an 710032, China.

出版信息

Int J Biol Macromol. 2025 Jul;318(Pt 1):145010. doi: 10.1016/j.ijbiomac.2025.145010. Epub 2025 Jun 5.

DOI:10.1016/j.ijbiomac.2025.145010
PMID:40482741
Abstract

Apparently, mRNA vaccines have played a pivotal role in curbing the further spread of COVID-19. However, their deployment has been accompanied by reports of adverse events (AEs), including cardiovascular and neurological symptoms. The comprehensive review proposes a conceptual framework to better characterize AEs, elucidate the underlying mechanisms, and outline therapeutic strategies. It also profiles AEs into a three-axe mechanism classification: host susceptibility, delivery system interactions, and mRNA component immunogenicity, thereby advancing current understanding of their etiology. Finally, the analysis integrates these axes with critical perspectives - mRNA molecular design, platform-specific toxicity, and human nature - to provide a comprehensive roadmap for addressing above issues.

摘要

显然,mRNA疫苗在遏制新冠病毒的进一步传播中发挥了关键作用。然而,其应用伴随着不良事件(AE)的报告,包括心血管和神经症状。这项全面综述提出了一个概念框架,以更好地表征不良事件、阐明潜在机制并概述治疗策略。它还将不良事件归纳为一种三轴机制分类:宿主易感性、递送系统相互作用和mRNA成分免疫原性,从而推进了目前对其病因的理解。最后,该分析将这些轴与关键观点——mRNA分子设计、平台特异性毒性和人性——相结合,以提供一个解决上述问题的全面路线图。

相似文献

1
[Illuminating the shadows - perspectives on mRNA vaccine adverse events - mechanisms, risks and management]: A review.[照亮阴影——mRNA疫苗不良事件的观点——机制、风险与管理]:一篇综述
Int J Biol Macromol. 2025 Jul;318(Pt 1):145010. doi: 10.1016/j.ijbiomac.2025.145010. Epub 2025 Jun 5.
2
A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines.一种用于mRNA疫苗研发与优化的多尺度定量系统药理学模型。
CPT Pharmacometrics Syst Pharmacol. 2025 Jul;14(7):1213-1224. doi: 10.1002/psp4.70041. Epub 2025 May 26.
3
Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review.SARS-CoV-2 mRNA疫苗在儿童和成人风湿病患者中的安全性、有效性和免疫原性:一项综合文献综述
Rheumatol Int. 2024 Dec;44(12):2757-2794. doi: 10.1007/s00296-024-05734-x. Epub 2024 Nov 22.
4
Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.检测人乳中 SARS-CoV-2 特异性抗体及其在 COVID-19 疫苗接种后的中和能力:系统评价。
Int J Mol Sci. 2023 Feb 3;24(3):2957. doi: 10.3390/ijms24032957.
5
Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals.一种新型多价抗SARS-CoV-2 mRNA疫苗在实验动物中的有效性和安全性。
Sci Rep. 2025 Jul 1;15(1):21831. doi: 10.1038/s41598-025-07661-8.
6
Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress.推进用于传染病的信使核糖核酸疫苗:关键组成部分、创新与临床进展
Essays Biochem. 2025 May 1;69(2):EBC20253009. doi: 10.1042/EBC20253009.
7
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study.一种单价奥密克戎XBB.1.5 SARS-CoV-2重组刺突蛋白疫苗在既往未接种过疫苗、SARS-CoV-2血清阳性参与者中的免疫原性和安全性:一项2/3期开放标签研究的第28天初步分析
Vaccine. 2025 May 10;55:127046. doi: 10.1016/j.vaccine.2025.127046. Epub 2025 Apr 2.
8
Unexpected renal side effects of mRNA COVID-19 vaccines; a single-center experience and short review.mRNA新冠疫苗意外的肾脏副作用:单中心经验及简要综述
Am J Med Sci. 2025 Jun;369(6):739-744. doi: 10.1016/j.amjms.2025.01.002. Epub 2025 Jan 7.
9
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.一种编码严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎XBB.1.5受体结合结构域的信使核糖核酸(mRNA)疫苗可保护小鼠免受JN.1变体的感染。
EBioMedicine. 2025 Jun 6;117:105794. doi: 10.1016/j.ebiom.2025.105794.
10
mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial.健康成年人中基于mRNA的季节性流感和SARS-CoV-2多组分疫苗:一项1/2期试验。
Nat Med. 2025 May;31(5):1484-1493. doi: 10.1038/s41591-025-03591-0. Epub 2025 Mar 18.

引用本文的文献

1
Multisystem Endothelial Inflammation: A Key Driver of Adverse Events Following mRNA-Containing COVID-19 Vaccines.多系统内皮炎症:含mRNA的新冠疫苗接种后不良事件的关键驱动因素
Vaccines (Basel). 2025 Aug 12;13(8):855. doi: 10.3390/vaccines13080855.